3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 34.60
-1.30 (-3.62%)
Apr 29, 2026, 1:25 PM CST
3D Global Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 17.45 | 56.12 | 21.82 | 15.53 | 20.37 | Upgrade
|
| Short-Term Investments | 459.8 | 647.74 | 144.2 | 192.9 | 212.8 | Upgrade
|
| Cash & Short-Term Investments | 477.25 | 703.86 | 166.02 | 208.43 | 233.17 | Upgrade
|
| Cash Growth | -32.20% | 323.97% | -20.35% | -10.61% | -15.74% | Upgrade
|
| Accounts Receivable | 71.98 | 119.58 | 1.35 | 1.09 | 1.23 | Upgrade
|
| Other Receivables | 1 | 2.99 | 0.59 | 0.44 | 0.41 | Upgrade
|
| Receivables | 72.98 | 122.57 | 1.94 | 1.53 | 1.64 | Upgrade
|
| Inventory | 22.38 | 7.04 | 3.6 | 3.37 | 0.88 | Upgrade
|
| Other Current Assets | 1.9 | 2.34 | 4.12 | 2.68 | 4.15 | Upgrade
|
| Total Current Assets | 574.51 | 835.81 | 175.67 | 216.01 | 239.85 | Upgrade
|
| Property, Plant & Equipment | 59.82 | 92.77 | 13.15 | 21.02 | 28.17 | Upgrade
|
| Long-Term Investments | 355.6 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 73.17 | 87.79 | 102.29 | 117.09 | 152.3 | Upgrade
|
| Long-Term Deferred Tax Assets | 26.21 | 18.56 | 16.27 | 15.31 | 3.2 | Upgrade
|
| Other Long-Term Assets | 1.34 | 2.65 | 16.77 | 1.84 | 0.99 | Upgrade
|
| Total Assets | 1,091 | 1,038 | 324.15 | 371.26 | 424.52 | Upgrade
|
| Accounts Payable | 2.77 | 16.08 | 3.33 | 2.22 | 0.67 | Upgrade
|
| Accrued Expenses | 13.02 | 14.34 | 7.69 | 7.61 | 6.35 | Upgrade
|
| Current Portion of Leases | 7.02 | 11 | 6.3 | 6.37 | 5.5 | Upgrade
|
| Current Unearned Revenue | 14.4 | 6.63 | 7.31 | 2.22 | - | Upgrade
|
| Other Current Liabilities | 3.59 | 4.41 | 1.87 | 1.74 | 2.44 | Upgrade
|
| Total Current Liabilities | 40.8 | 52.46 | 26.49 | 20.17 | 14.95 | Upgrade
|
| Long-Term Leases | 41.63 | 73.77 | 4.08 | 10.38 | 15.81 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 23.69 | 6.65 | - | - | 3.94 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.11 | 0.11 | 0.11 | Upgrade
|
| Total Liabilities | 106.12 | 132.88 | 30.68 | 30.66 | 34.81 | Upgrade
|
| Common Stock | 778.4 | 778.4 | 568.09 | 557.4 | 539.7 | Upgrade
|
| Additional Paid-In Capital | 37.76 | 34.59 | 1.22 | 2.08 | 1.8 | Upgrade
|
| Retained Earnings | 116.96 | 91.7 | -275.84 | -218.88 | -151.79 | Upgrade
|
| Treasury Stock | -43.02 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 94.43 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 984.53 | 904.69 | 293.47 | 340.6 | 389.71 | Upgrade
|
| Total Liabilities & Equity | 1,091 | 1,038 | 324.15 | 371.26 | 424.52 | Upgrade
|
| Total Debt | 48.66 | 84.76 | 10.38 | 16.75 | 21.31 | Upgrade
|
| Net Cash (Debt) | 428.59 | 619.1 | 155.64 | 191.68 | 211.87 | Upgrade
|
| Net Cash Growth | -30.77% | 297.78% | -18.80% | -9.53% | -17.22% | Upgrade
|
| Net Cash Per Share | 5.41 | 8.75 | 2.77 | 3.49 | 3.93 | Upgrade
|
| Filing Date Shares Outstanding | 153.96 | 77.84 | 56.81 | 55.74 | 53.97 | Upgrade
|
| Total Common Shares Outstanding | 153.96 | 77.84 | 56.81 | 55.74 | 53.97 | Upgrade
|
| Working Capital | 533.71 | 783.35 | 149.17 | 195.84 | 224.9 | Upgrade
|
| Book Value Per Share | 6.39 | 11.62 | 5.17 | 6.11 | 7.22 | Upgrade
|
| Tangible Book Value | 911.36 | 816.91 | 191.18 | 223.52 | 237.41 | Upgrade
|
| Tangible Book Value Per Share | 5.92 | 10.49 | 3.37 | 4.01 | 4.40 | Upgrade
|
| Machinery | 25.29 | 20.25 | 14.61 | 14.38 | 13.77 | Upgrade
|
| Leasehold Improvements | 13.25 | 13.15 | 12.57 | 12.57 | 12.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.